中国实用妇科与产科杂志

中国实用妇科与产科杂志 ›› 2022, Vol. 38 ›› Issue (7): 691-693.DOI: 10.19538/j.fk2022070106

• 专题笔谈 • 上一篇    下一篇

高危妊娠滋养细胞肿瘤的治疗

  

  1. 四川大学华西第二医院妇产科/出生缺陷与相关妇儿疾病教育部重点实验室，四川 成都 610041
  • 出版日期:2022-07-02 发布日期:2022-07-02
  • 通讯作者: 尹如铁
  • 基金资助:
     四川省科学技术厅重点研发项目（19ZDYF）；成都市科技项目重点研发支撑计划（2021-YF05-01725-SN）

Treatment for high-risk gestational trophoblastic neoplasia.

  1. Department of Gynecology and Obstetrics，West China Second University Hospital，Sichuan University & Key Laboratory of Birth Defects and Related Diseases of Women and Children（Sichuan University），Ministry of Education，Chengdu 610041，China
  • Online:2022-07-02 Published:2022-07-02

摘要： 高危妊娠滋养细胞肿瘤的治疗原则是联合化疗为主，手术、放疗、靶向和免疫等综合治疗为辅，总的来讲预后良好，但仍有患者因肿瘤复发耐药而死亡。文章对近年来高危妊娠滋养细胞肿瘤的治疗进展做一概述，为临床治疗提供参考。

关键词: 妊娠滋养细胞肿瘤, 高危, 治疗, 化疗

Abstract: The treatment principle of high-risk gestational trophoblastic neoplasia is mainly the combined chemotherapy，supplemented by comprehensive treatment such as surgery，radiotherapy，targeted and immune therapy. In general，the prognosis is good，but there are still patients who die due to tumor recurrence and drug resistance. This article summarizes the recent progress in the treatment of high-risk gestational trophoblastic neoplasia and provides a reference for clinical treatment.

Key words: gestational trophoblastic neoplasia, high-risk, treatment, chemotherapy

中图分类号: